Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Disease × Mitomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 34 Non-Muscle Invasive Bladder Neoplasms 22 Colorectal Neoplasms 17 Anus Neoplasms 16 Carcinoma, Transitional Cell 12 Carcinoma, Hepatocellular 10 Neoplasm Metastasis 9 Appendiceal Neoplasms 9 Stomach Neoplasms 8 Peritoneal Neoplasms 7 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 6 Liver Neoplasms 5 Colonic Neoplasms 5 Rectal Neoplasms 4 Sarcoma 3 Pseudomyxoma Peritonei 3 Neoplasms 3 Mesothelioma, Malignant 3 Gastrointestinal Neoplasms 3 Carcinoma 3 Breast Neoplasms 3 Anal Canal Carcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Ovarian Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma in Situ 2 Virus Diseases 1 Uterine Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Blood Specimen Collection 6 Cyclophosphamide 5 Prednisone 4 Positron Emission Tomography Computed Tomography 4 Mammography 4 Lenalidomide 4 Colonoscopy 4 Tomography, X-Ray Computed 3 Surveys and Questionnaires 3 Melphalan 3 Biopsy 3 weifuchun 2 pembrolizumab 2 fluciclovine F-18 2 daratumumab 2 carfilzomib 2 Preoperative Exercise 2 Positron-Emission Tomography 2 Methods 2 Magnetic Resonance Imaging 2 Injections 2 Gemcitabine 2 Cytarabine 2 Control Groups 2 Biopsy, Fine-Needle 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 vistusertib 1 venetoclax 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03335059 2020-04-15

RITE-USA

Medical Enterprises Ltd.

Phase 3 Terminated

Urinary Bladder Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡